Company News

October 16, 2008 open Exhibiting at the NIH Research Festival

June 23, 2008 display Akron - an Approved SciQuest Supplier: Akron Biotech is pleased to announce that it is now a SciQuest approved supplier. As of June 2008, our high quality cell culture products are offered to SciQuest users through its Scientific Catalogue, easing the procurement process for those who enjoy SciQuest services.

April 01, 2008 open 'Wonder Women, Power Players Share Valuable Life Lessons', The Boca Raton Observer, April 2008

October 19, 2007 visit 'New Biotech Opens in Boca', South Florida Business Journal, October 19-25, 2007

October 08, 2007 display Akron Biotech is moving to a new location: Akron Biotechnology (Akron Biotech) is pleased to announce the relocation of their headquarters to the Florida Atlantic University (FAU) Research & Development Park in Boca Raton, Florida.

This move has been greatly anticipated due to the rapid growth of our company. Our new office provides us with more space to expand our operations and also features a new state-of-the-art laboratory.
As we continue make these types of enhancements to our business, we are providing more examples of our commitment to superior customer service and excellent quality products.

Akron Biotech is a global product supplier of bulk and small quantities of Reagents, Animal Serum and Cell Culture products for research and development. The Company has manufacturing facilities worldwide.

Our new contact info is:

3998 FAU Blvd. Suite 210, Boca Raton, FL 33431
Ph: 561.750.6120
Fax:561.750.6140
Toll-Free Ph: 1-888-70Akron(25766)

To learn more about Akron Biotech and its products please visit our website at www.akronbiotech.com or contact us at Ph 561.750.6120/ Toll-Free 888-70AKRON

About Akron Biotech

Akron Biotech provides its customers with superior quality Serum, Reagent and Cell Culture products for Research and Development. As a global product supplier, Akron Biotech specializes in manufacturing and supplying cell culture and cell biology products aimed at the biopharmaceutical and biotechnology markets. Our mission is to be a leading global biotechnological service and manufacturing company focused on providing stellar research and manufacturingcapabilities to assist our clients in achieving their critical research goals. Our network of clients includes large Research and Development Reagent companies and contract research organizations

September 26, 2007 display Mycoplasma Detection Kit and Treatment now available at Akron Biotech: BOCA RATON, FL, Sept 26/PRNews Akron Biotech is now offering best-in-class series of Mycoplasma products for the detection and elimination of contaminated cultures. The MycoSolutionsTM line of products will be added to the currently offered product pool that consists of small and bulk quantities of high quality Animal Sera, Biological Reagents, and Cell Culture products.

MycoSolutions TM Detection Kit is designed to reveal the presence of mycoplasma as a contaminant in biological materials, such as cultured cells. The product is an optimized ready-to-use PCR Detection Kit so that mycoplasma can be easily detected by verifying the bands of amplified DNA fragments in an electrophoresis gel.

MycoSolutionTM-1, MycoSolutionTM-2, MycoSolutionTM-3 are antibiotic formulations designed to treat Mycoplasma contaminated cultures. The contamination of cells with mycoplasma is a very common problem, even thoughit often goes unnoticed since no cloudiness appears in the cell culture. Nevertheless the contamination often causes biochemical changes as well as changes in the immunological properties of the cells. Since mycoplasma-infected cells cannot always be discarded, many complicated methods have been suggested for the elimination of the mycoplasma.

Akron Biotech's MycoSolutionTM-1, MycoSolutionTM-2, MycoSolutionTM-3 have been shown to be effective in the elimination of mycoplasma species that account for 90% of the contamination found in cell cultures.
To learn more about the MycoSolutionsTM series or for a complete list of Akron Biotech's other leading products, please visit our website at www.akronbiotech.com or contact us at Ph 561.750.6120/Toll-Free 888.70AKRON

About Akron Biotech

Akron Biotech provides its customers with superior quality Serum and Reagent products for Research and Development.
As a global product supplier, Akron Biotech specializes in manufacturing and supplying cell culture and cell biology products aimed at the biopharmaceutical and biotechnology markets. Our mission is to be a leading global biotechnological service and manufacturing company focused on providing stellar research and manufacturing capabilities to assist our clients in achieving their critical research goals. Our network of clients includes large Research and Development reagent companies and contract research organizations. For a complete list of all products visit our website at www.akronbiotech.com or contact us at Akron Biotechnology, LLC, 3998 FAU Blvd., Suite 210, Boca Raton, FL 33431
Ph/Fax: 561.750.6120/561.750.6120

July 31, 2007 display Akron Biotech Launches a new line of Serum-Free Cell Culture Products: BOCA RATON, FL, July 31/PRNews Akron Biotech announces the launching of a line of Serum-Free Media products that will be added to its ever expanding product pipeline. The company which currently offers bulk quantities of high quality Animal Sera and Biological Reagents, now offers high quality serum free media.

"It is our priority to keep up with today's innovative technology and emerging demands in the fast growing and evolving field of biotechnology. We have found that formulations containing limited or no animal derived products, have become essential for the future growth of our customers and the biotechnology industries in general," said Founder and CEO, Claudia Zylberberg, PhD. Akron Biotech's Serum-free Media, Supplements and Additional Products are all produced in ISO 9001 and ISO 13485 certified facility. The animal products that are used in these media are all from USA sources.

Akron Biotech plans to fulfill those demands, by making available to its US and International customers its high quality Serum Free Media products that are for use with all commercially significant cell culture.

Here are a few of the products in the series:

-AK-Media hi
-AK-Media mid
-AK-Media lo (BSA-free variation)

AK-GROW hi and AK-GROW lo have been successfully used in all of the following cell culture applications:

-Myeloma and hybridoma cell cultures
-Monoclonal antibody production
-Primary Lymphocyte Cultures (including stimulated or transformed cells)
-Viral production

In addition, AK-GROW hi and AK-GROW lo are serum-free medium supplements products, intended for those customers who prefer their own final medium, using a basal media of their choice. AK-GROW hi contains albumin, whereas AK-GROW lo is a very low protein albumin-free formulation.

For a complete list of all Serum-Free Media products or Akron Biotech's other leading products, please visit our website at www.akronbiotech.com or contact Patricia Keating at Akron Biotechnology, LLC, 3998 FAU Blvd., Suite 210, Boca Raton, FL 33431.
Ph 561.750.6120/ Toll-Free 888-70AKRON

About Akron Biotech

Akron Biotech provides its customers with superior quality Serum and Reagent products for Research and Development.
As a global product supplier, Akron Biotech specializes in manufacturing and supplying cell culture and cell biology products aimed at the biopharmaceutical and biotechnology markets. Our mission is to be a leading global biotechnological service and manufacturing company focused on providing stellar research and manufacturing capabilities to assist our clients in achieving their critical research goals. Our network of clients includes large Research and Development reagent companies and contract research organizations. For a complete list of all products visit our website at www.akronbiotech.com or contact us at Akron Biotechnology, 3998 FAU Blvd., Suite 210, Boca Raton, FL 33431
Ph/Fax: 561.750.6120/561.750.6140

June 16, 2007 display Second Annual International Serum Industry Association (ISIA) meeting held in Germany: The International Serum Industry Association held its second annual meeting in Dresden, Germany on June 16-17, 2007. On the agenda, regulatory activities progress in connection with DEFRA, FDA and USDA and SANCO and the advancement of other association committees.

Incorporated in June 2006, the ISIA's first annual meeting was held a month after that, with participation from more than 20 leading companies in the serum industry.

The association's mission was to establish, promote and assure compliance with uncompromised standards of excellence and ethics in the business practices of the global animal serum supply industry. Its primary focus was on safety and safe use of serum through proper origin traceability and truth in labeling, and appropriate standardization and oversight. The association also worked on educating the stakeholders on the scientific foundation of the safe use of serum.

March 08, 2007 display Akron Biotechnology and Leloir Institute join forces: Akron Biotechnology (Akron Biotech), a Boca Raton, Florida based biotechnology company providing best-in-class animal serum and unique biological reagents for superior research and development announced their recently signed partnership agreement with the world renowned Leloir Institute. For Akron Biotech, this partnership agreement marks the first critical milestone being met for the 2007 year.

Based in Buenos Aires, Argentina, Leloir Institute is well known for receiving a Nobel Prize in Chemistry for its discoveries in the biosynthesis of Glycoproteins, and its continued dedication to the creation of knowledge and dissemination of Biochemistry and Molecular Biology through research and teaching.

Formerly known as "Campomar Foundation Institute for Biochemical Research", the Leloir Institute was founded by Dr. Luis Federico Leloir and Dr. Carlos E. Cardini. It is dedicated to basic research in Biochemistry and Molecular Biology and its efforts may have a profound effect in understanding the nature of as well as possibly finding ways for curing disorders such as Cancer, Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Chagas disease and the processes of Neurogenesis, among others.

The Institute occupies a 21,000 square foot building. Its staff includes 20 senior researchers, 12 associate researchers, 20 post doctoral fellows, more than 80 PhD candidates, and 42 technicians and administrative personnel.

"The alliance will add greatly to Akron Biotech's competitive advantage as it will place the company in the front line for new product development in the area of reagents, recombinant proteins, monoclonal and polyclonal antibodies, and novel technology advancements that can be applied in the Research and Development arena," said Claudia Zylberberg PhD., Chief Executive Officer and Co-Founder of Akron Biotech.

For more information about Akron Biotech, please visit our website at www.akronbiotech.com or contact us at Akron Biotechnology, LLC, 3998 FAU Blvd., Suite 210, Boca Raton,
FL 33431, Ph 561.750.6120/ Fax 561.750.6140.

For more information about the Leloir Institute, visit their website at www.leloir.org.ar.